Writing Code and Printing Life: A Look into the Future of DNA

The year 2014 was a good one for Austen Heinz. Cambrian Genomics, his modest start-up of 11 employees, raised $10 million in investment money. For a small company, Cambrian has nailed down contracts with some big-time partners, including pharmaceutical companies GlaxoSmithKline (2013 revenue = $38 billion) and Roche (2014 revenue

Read more

GMO A Go-Go: Understanding the Science Behind Engineered Crops

In case you missed the state’s headlines over Fall Break, the Los Angeles City Council passed a resolution Oct. 21 prohibiting the cultivation of genetically modified (GM) seeds in Los Angeles.  While that may seem like welcome news against the backdrop of the media’s obsession with the Ebola-ISIS-Putin Axis of

Read more